Similar to the results of Amodio et al.22, EGF treatment rapidly activated the ERK cascade and PI3K/AKT signaling in these 2 KRAS-mutant CRC cell lines, as evidenced by high levels of activated pMEK, pERK, and pAKT. The gene discussed is EIF2AK3; the disease is colorectal carcinoma.